# The interplay of ferroptosis and oxidative stress in pulmonary fibrosis: from mechanisms to treatment

**Authors:** Peishuo Yan, Junjie Wang, Zhen Lei, Hongbo Chang, Weili Shi, Shangzeng Wang

PMC · DOI: 10.3389/fcell.2026.1709805 · Frontiers in Cell and Developmental Biology · 2026-03-09

## TL;DR

This paper reviews how ferroptosis, a type of cell death linked to oxidative stress, contributes to pulmonary fibrosis and explores its potential as a target for new treatments.

## Contribution

The paper provides a systematic review of cell-type-specific roles of ferroptosis in pulmonary fibrosis and identifies potential therapeutic targets.

## Key findings

- Ferroptosis plays a significant role in pulmonary fibrosis through oxidative stress and lipid peroxidation.
- Small-molecule inhibitors targeting ferroptosis show anti-fibrotic effects in animal models.
- Ferroptosis represents a critical regulatory node linking metabolism and cell fate in PF progression.

## Abstract

Pulmonary fibrosis (PF) is a progressive and devastating interstitial lung disease characterized by the dynamic imbalance of multiple cell types and signaling pathways. In recent years, ferroptosis, an iron-dependent form of programmed cell death driven by lipid peroxidation, has been recognized as playing a significant role in the progression of pulmonary fibrosis due to its central role in oxidative stress, metabolic dysfunction, and disruption of barrier integrity. Existing studies have elucidated the core signaling pathways, key molecules, and potential roles of ferroptosis in PF progression, highlighting the synergistic pathogenic effects of iron homeostasis disruption and lipid peroxidation. Despite its established role in fibrosis, a comprehensive analysis of the cell-type-specific mechanisms of ferroptosis within pulmonary cell populations remains lacking. Furthermore, several small-molecule inhibitors targeting ferroptosis have demonstrated promising anti-fibrotic effects in animal models, yet their tissue-specificity, safety profiles, and clinical feasibility warrant further investigation. This review systematically summarizes the cell-type-specific roles of ferroptosis in PF, delineates the key molecular mechanisms and potential druggable targets involved, and underscores the potential of ferroptosis as a critical regulatory node at the intersection of metabolism and cell fate. By bridging the understanding of metabolic regulation and cell death processes, ferroptosis holds promise for providing novel mechanistic insights and informing precise therapeutic strategies for pulmonary fibrosis.

## Linked entities

- **Diseases:** pulmonary fibrosis (MONDO:0002771)

## Full-text entities

- **Diseases:** PF (MESH:D011658), fibrosis (MESH:D005355), interstitial lung disease (MESH:D017563), metabolic dysfunction (MESH:D008659)
- **Chemicals:** lipid (MESH:D008055), iron (MESH:D007501)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13006651/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13006651/full.md

## References

200 references — full list in the complete paper: https://tomesphere.com/paper/PMC13006651/full.md

---
Source: https://tomesphere.com/paper/PMC13006651